REPR - Repro Med Systems, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5118.78M
Enterprise Value 3112.46M
Trailing P/E 387.50
Forward P/E 144.29
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)6.49
Price/Book (mrq)12.92
Enterprise Value/Revenue 36.15
Enterprise Value/EBITDA 676.68

Trading Information

Stock Price History

Beta (3Y Monthly) -0.09
52-Week Change 3156.30%
S&P500 52-Week Change 37.70%
52 Week High 33.1800
52 Week Low 31.1800
50-Day Moving Average 32.4090
200-Day Moving Average 31.7536

Share Statistics

Avg Vol (3 month) 348.47k
Avg Vol (10 day) 397.18k
Shares Outstanding 538.32M
Float 22.7M
% Held by Insiders 144.43%
% Held by Institutions 117.96%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin 2.31%
Operating Margin (ttm)6.28%

Management Effectiveness

Return on Assets (ttm)6.86%
Return on Equity (ttm)4.88%

Income Statement

Revenue (ttm)18.29M
Revenue Per Share (ttm)0.48
Quarterly Revenue Growth (yoy)23.30%
Gross Profit (ttm)10.81M
EBITDA 1.47M
Net Income Avi to Common (ttm)421.75k
Diluted EPS (ttm)0.0080
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)4.12M
Total Cash Per Share (mrq)0.11
Total Debt (mrq)477.56k
Total Debt/Equity (mrq)5.21
Current Ratio (mrq)4.72
Book Value Per Share (mrq)0.24

Cash Flow Statement

Operating Cash Flow (ttm)447.54k
Levered Free Cash Flow (ttm)197.2k